Shockwave Medical Inc (SWAV) Financials

$334.75

$0.00 (0.00%)

As on 31-May-2024 09:30EDT

Market cap

$12,568 Mln

Revenue (TTM)

$788 Mln

P/E Ratio

78.8

P/B Ratio

18.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Operating Revenue	787.97	730.23	489.73	237.15	67.79	42.93
Cost of Revenue	102.53	95.39	65.00	41.44	20.99	17.16
Gross Profit	685.44	634.84	424.74	195.71	46.80	25.77
Operating Expenses	522.45	468.85	300.60	196.58	112.46	77.61
Operating Profit (EBIT)	162.99	165.99	124.13	-0.87	-65.66	-51.84
Other Income	1.44	--	--	-6.87	1.26	--
Profit before Tax	183.54	174.28	120.83	-8.84	-65.62	-51.05
Provision for Tax	20.04	27.00	-95.17	0.30	0.08	0.06
Profit after Tax (Net Income)	163.50	147.28	216.00	-9.14	-65.70	-51.11
Minority Interest	--	--	--	--	--	--
Consolidated Profit	28.86	--	216.00	-9.14	-65.70	-51.11

Liabilities ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Shareholder's Funds	751.76	668.68	511.32	241.83	225.65	192.65
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	799.66	793.68	71.40	52.22	20.81	15.28
Current Liabilities	92.33	104.21	63.37	51.63	25.58	24.01
Total Liabilities	1,736.08	1,566.56	646.09	345.68	272.04	231.94

Assets ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Non-Current Assets	368.40	341.30	186.83	59.78	25.74	15.24
Current Assets	1,275.35	1,225.26	459.26	285.90	246.30	216.70
Total Assets	1,736.08	1,566.56	646.09	345.68	272.04	231.94
Total Debt*	776.80	770.61	60.40	47.19	24.98	22.72
Net Current Assets	1,183.02	1,121.06	395.89	234.27	220.72	192.69

Cashflow ($ Mln)	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Cash From Operating Activities	--	196.05	117.73	15.04	-71.18	-48.11
Cash Flow from Investing Activities	--	--	-62.15	26.42	-107.47	-59.54
Cash from Financing Activities	--	600.40	13.00	-2.45	90.04	208.05
Net Cash Inflow / Outflow	--	--	--	39.00	-88.62	--

Financials Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Adjusted EPS ($)	4.30	3.88	5.68	-0.26	-1.99	-2.13
Cash EPS ($)	--	4.15	5.81	-0.10	-1.89	-2.03
Adjusted Book Value ($)	--	17.60	13.46	6.91	6.84	8.03
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	5.16	3.10	0.43	-2.16	-2.00
Free Cash Flow per Share ($)	--	4.35	2.44	0.07	-2.51	-2.16

Profitability Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
ROCE (%)	--	14.65	50.19	-3.39	-28.20	-39.17
ROE (%)	24.17	24.96	57.36	-3.91	-31.41	-45.80
ROA (%)	12.29	13.31	43.56	-2.96	-26.07	-35.82
EBIT Margin (%)	22.00	22.73	25.35	-0.37	-96.86	-120.76
Net Margin (%)	20.71	20.17	44.10	-3.97	-95.15	-119.06
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Revenue Growth (%)	41.42	0.49	1.07	2.50	0.58	2.50
EBIT Growth (%)	16.68	33.72	14,351.89	98.67	-26.67	-27.65
Net Profit Growth (%)	-32.05	-31.81	2,464.23	86.09	-28.55	-24.35
EPS Growth (%)	-32.05	-0.32	22.78	0.87	0.07	0.90
Book Value Growth (%)	31.73	--	--	--	--	--

Valuation Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Price / Earnings	78.76	49.17	36.17	-683.18	-52.10	-20.62
Price / Book Value	18.38	10.83	15.28	25.81	15.17	5.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	63.03	39.81	61.68	-786.63	-50.39	-17.81
Close Price ($)	325.63	190.56	205.61	178.33	103.72	43.92
High Price ($)	331.58	315.95	320.54	249.73	105.09	68.39
Low Price ($)	157.00	157.00	113.36	91.47	22.01	24.58
Market Cap ($ Cr)	12,567.69	--	--	--	--	--

Solvency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debt to Equity	0.97	1.15	0.12	0.20	0.11	0.12
Short term debt to equity ratio	0.00	0.01	0.00	0.03	0.02	0.04
Current Ratio	13.81	11.76	7.25	5.54	9.63	9.03
Quick Ratio	12.61	10.73	6.06	4.71	8.46	8.52
Interest Coverage	20.92	26.79	65.82	-0.79	-54.18	-54.91

Operating Efficiency Ratios	TTM	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14
Debtors to sales (%)	15.79	15.69	14.57	15.79	17.24	17.18
Asset Turnover	0.59	0.66	0.99	0.77	0.27	0.30
Receivable days	--	46.50	40.57	37.83	51.36	43.51
Inventory Days	--	349.79	331.81	321.01	364.82	183.11
Payable days	--	29.85	28.78	21.97	37.03	45.52
Cash Conversion Cycle	--	366.44	343.61	336.86	379.16	181.10

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.